Clinical trial · Interventional
DaHuang GangTsao Tang to Improve the Appetite Loss Condition of Cancer Patients
Taking Herbal Formula：DaHuang GangTsao Tang to Improve the Appetite Loss Condition of Cancer Patients in Late-stage：A Clinical Control Trial Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Appetite loss is a severe and common symptom among late-stage cancer patients, and it causes great the anxiety for the patient's family. In TCM theory, the investigators call these patients are in block and repulsion condition. The investigators try to set a study to use the herbal medicine solution taken in frequent small amounts by cancer patients in late-stage to improve the appetite loss condition. Through this method, the investigators not only want to improve the quality of life of cancer patients in late-stage but also set a valuable treatment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non-organic Loss of Appetite | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| DaHuang GanTsao Tang | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- herbal medicine
- description
- Intervention group * 1\. 2 grams of DaHuang abstract powder and 0.5 grams GanTsao abstract powder are mixed and separated into four packages; * 2\. each package was given to each patient four times a day (three time after meal and one time before sleep); * 3\. each patient received the usual medication of the hospice ward at the same time; * 4\. record the patients' score of pre-test, mid-test and after-test of QIPCTP at the 1st day, the 3rd day and the 6th day; * 5\. record the patients' score of EORTC QLQ-C30 V3.0 and ECOG (Eastern Cooperative Oncology Group Performance Status) at the 1st day and the 6th day.
- interventionNames
- Drug: DaHuang GanTsao Tang
Primary outcomes (1)
- measure
- appetite score
- timeFrame
- 6 days
- description
- The investigators detect the patients' appetite condition at the 1st,3rd and 6th day.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Terminal cancer patients in hospice ward * Patients with appetite loss condition * Ages between 20 to 80 years old * No history of diabetes Exclusion Criteria: * Entered the stage of dying patients * Receiving other traditional Chinese medicine
References
Publications (0)
Data not yet available